Navigation Links
Senesco Technologies to Present at BIO 2008 Business Forum
Date:6/12/2008

to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products. Senesco is headquartered in New Brunswick, N.J.

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors, including, but not limited to: the development of the Company's gene technology; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs and joint ventures; the success of the Company's license agreements; the successful conversion of the Company's letter of intent into a license agreement; the acceptance by the market of the Company's products; success of the Company's preliminary studies and preclinical research; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


'/>"/>
SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
2. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
3. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
4. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
5. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
6. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
7. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
8. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
9. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
10. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
11. Pelikan Technologies Appoints Denny Ware to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... December 15 , ... to Evaluate the Ability of,Cardiopoietic Cells to Restore ... BioSciences, a leading Belgian biotechnology company specialising,in cell-based ... that it has completed, two months ahead of ... Phase II/III trial of C-Cure, a,unique stem cell ...
(Date:12/14/2009)... Calif., Dec. 14 Array BioPharma Inc. ... AMGN ) today announced that they entered into ... Array,s small-molecule glucokinase activator program, including ARRY-403, currently ... in patients with Type 2 diabetes. ... will receive an upfront payment of $60 million ...
(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... 4 deCODE genetics,(Nasdaq: DCGN ) today announced ... Kari Stefansson,s presentation at the JPMorgan 26th Annual Healthcare,Conference., ... PST / 7:30 pm GMT on,Thursday, January 10 at ... be accessed through the Investors page on deCODE,s website, ...
... - VELCADE(R) (bortezomib) for Injection sales grew 20% to $265 million in ... ... front-line multiple myeloma -,- MLN0002 core bridging studies fully enrolled, showing favorable results ... - On track to exceed 2007 net income ...
... AutoGenomics announced today,that the Company has been invited and ... is being held January 7-10, 2008 at,the Westin St. ... Kureshy President and Chief Executive Officer will provide an,overview ... 8, 2008., About JPMorgan 26th Annual Healthcare Conference, ...
Other Biology Technology:Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 2Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 3Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 4Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 5Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 6Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 7Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 8Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results 9
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... for premium fruit increases, growers are being challenged ... to boost their bottom line, orchard owners are ... quality while reducing labor costs. , Hand thinning, ... larger, healthier fruit, is among the most labor-intensive ... fruit production overhead, and, ultimately, prices paid by ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3New genes for lung disease discovered 2Horizontal string trimmer reduces labor costs, increases peach size 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 1SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 3SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 4LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 1LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 2Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 1Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 2
... that oversees childhood vaccinations today recommended a new ... common childhood illness that is the single largest ... worldwide. Three scientists associated with The Children's Hospital ... of the vaccine, based on research dating to ...
... If mastering flight is your goal, you can't do better ... the standard two and an unusual pitching stroke that allows ... slender, elegant insect is a marvel of engineering. , Z. ... University, presented her research on flying systems and fluid dynamics ...
... Society of Plastic Surgeons (ASPS) and the American ... landmark joint document, Facial Transplantation-ASPS/ASRM Guiding Principles, to ... procedures. , "This is truly a remarkable and ... MD and ASPS president. "The ability to help ...
Other Biology News:New Rotavirus vaccine joins routine infant immunization schedule 2Scientist uses dragonflies to better understand flight 2
Anti 4-hydroxy-2-hexenal (4-HHE) Monoclonal Antibody (HNEJ-2)...
... signals in immunostaining ,This solution has effect ... to get clearer signal than the one ... the amount of secondary antibody used and ... you can have images with high S/N ...
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
... tissues this enzyme exists predominantly as XDH ... acid, a critical plasma antioxidant. During ... oxygen radical producing XO by oxidation of ... proteolytic cleavage of the amino-terminus. AO ...
Biology Products: